Jove
Visualize
Contact Us

Related Experiment Videos

Orlistat use in type 2 diabetes.

Laura J Snider1, Margaret Malone

  • 1Clinical Nutrition, Albany College of Pharmacy, Albany, NY, USA. marathon-patlaura@aol.com

The Annals of Pharmacotherapy
|June 28, 2002
PubMed
Summary

Orlistat is a safe and effective medication for managing type 2 diabetes by aiding weight reduction and improving glycemic control. This medication can be a valuable addition to comprehensive treatment plans for diabetes patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Looking at the bid picture: A framework for identifying reverse auctions in ecological systems.

The Journal of animal ecology·2024
Same author

Pandemic, Civil Unrest, and a Tropical Storm - What Is Next? The Locusts??

Ochsner journal·2020
Same author

Sex-dependent effects of chronic variable stress on discrete corticotropin-releasing factor receptor 1 cell populations.

Physiology & behavior·2020
Same author

Characterization and gonadal hormone regulation of a sexually dimorphic corticotropin-releasing factor receptor 1 cell group.

The Journal of comparative neurology·2018
Same author

Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients.

Obesity surgery·2013
Same author

Management of iron deficiency and anemia after Roux-en-Y gastric bypass surgery: an observational study.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2013
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 2 diabetes is a chronic metabolic disorder characterized by hyperglycemia.
  • Weight management is crucial for effective type 2 diabetes treatment.
  • Orlistat is an FDA-approved medication for obesity treatment.

Purpose of the Study:

  • To review the efficacy and safety of orlistat in patients with type 2 diabetes.
  • To assess the impact of orlistat on glycemic control and weight reduction in this population.

Main Methods:

  • A comprehensive literature search was conducted using MEDLINE (1990-2001).
  • Key search terms included orlistat, obesity, glucose, and diabetes.
  • Emphasis was placed on randomized, placebo-controlled, double-blind clinical trials.

Main Results:

  • Orlistat demonstrated significant weight reduction in patients with type 2 diabetes.
  • Improved glycemic control was observed in patients treated with orlistat compared to placebo.
  • Two randomized controlled trials specifically reported these positive outcomes.

Conclusions:

  • Orlistat can be a safe and effective adjunct therapy for type 2 diabetes management.
  • Weight loss achieved with orlistat contributes to improved glycemic control.
  • Orlistat supports a multidisciplinary approach to managing type 2 diabetes.

Related Experiment Videos